VTGN

VISTAGEN THERAPEUTICS INC

VTGN·92840H400·US·Common Stock·Healthcare - Biotechnology-13D/G

VTGN (VISTAGEN THERAPEUTICS INC) is held by 29 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($355,769), TWO SIGMA INVESTMENTS, LP ($191,646), RENAISSANCE TECHNOLOGIES LLC ($165,093). Net institutional sentiment: Mixed.

29
Holders
$1.2M
Total Value
42% (31)
Consensus
13 buying - 18 selling
13F: Insider & Congress: Updated regularly
VTGN

Smart Money Verdict

View all
Loading verdict
Held by 29 funds

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders Jul 2, 2026 · Activists Aug 14, 2026 · Congress none

ActivistCYChen Yu6.7%Aug 14, 2026
ActivistCOCommodore Capital LP9.9%Aug 14, 2026
ActivistOAORBIMED ADVISORS LLC0.0%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Action
Unchanged
1.6M$355,7690.0%-64.79%
0
Increased
847,992(+80.6%)$191,6460.0%-81.13%
35
Increased
730,500(+150.8%)$165,0930.0%-78.89%
36
Decreased
365,002(-19.5%)$82,5140.0%-92.85%
0
Decreased
345,432(-23.0%)$78,0680.0%-92.02%
0
Increased
304,385(+1431.5%)$68,7910.0%-29.87%
34
Unchanged
217,700$49,2000.0%-64.79%
0
Decreased
164,827(-39.6%)$37,2510.0%-89.47%
0
Unchanged
121,114$27,3720.0%-93.60%
0
Decreased
118,380(-22.6%)$26,7540.0%-64.79%
0
Increased
80,823(+11.2%)$18,2660.0%-97.84%
14
New
68,839$15,5580.0%-6.61%
28
New
66,021$15,0000.0%-6.61%
25
Decreased
57,830(-26.6%)$13,0700.0%-84.68%
0
Increased
43,888(+961.9%)$10,0760.0%-75.00%
19
Unchanged
26,000$5,8760.0%-91.47%
0
Unchanged
20,628$4,6620.0%-93.00%
0
New
16,570$3,7450.0%-6.61%
21
New
15,000$3,3900.0%0.00%
21
Decreased
14,851(-0.2%)$3,3560.0%-64.79%
0

Showing 1-20 of 38

1 / 2
VTGNVTGNVISTAGEN THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used